TELA Bio (TELA) EPS (Basic) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.53% |
| Dec 31, 2025 | 10.53% |
| Sep 30, 2025 | 13.64% |
| Jun 30, 2025 | 12.00% |
| Mar 31, 2025 | -47.06% |
| Dec 31, 2024 | 59.52% |
| Sep 30, 2024 | 17.65% |
| Jun 30, 2024 | -121.74% |
| Mar 31, 2024 | 56.60% |
| Dec 31, 2023 | -17.78% |
| Sep 30, 2023 | 2.17% |
| Jun 30, 2023 | 26.98% |
| Mar 31, 2023 | -31.25% |
| Dec 31, 2022 | 25.00% |
| Sep 30, 2022 | 27.27% |
| Jun 30, 2022 | -17.33% |
| Mar 31, 2022 | -27.12% |
| Dec 31, 2021 | -3.51% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -1.79% |
| Mar 31, 2021 | -3.70% |
| Dec 31, 2020 | -1.89% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 15.87% |
| Mar 31, 2020 | -101.06% |
| Dec 31, 2019 | 363.60% |
| Sep 30, 2019 | 16.56% |
| Jun 30, 2019 | -0.22% |
| Mar 31, 2019 | 14.85% |
| Dec 31, 2018 | -100.19% |